First patients sought for groundbreaking gut cancer drug trial
Disease control
Not yet recruiting
This is the first-ever human study of an experimental drug called DB-1324 for people with advanced gastrointestinal cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and get an early look at whet…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC